2.23

1.55% -0.035

After Hours: 2.18 -0.05 -2.24%

Biomerica Inc (BMRA)

Overview News Price History Option Chain Financials Why BMRA Down? Discussions Forecast Stock Split

Biomerica Inc stock is traded at $2.23, with a volume of 14,673. It is down -1.55% in the last 24 hours and up +36.81% over the past month. Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Previous Close:

$2.265

Open:

$2.1701

24h Volume:

14,673

Relative Volume:

0.22

Market Cap:

$10.23M

Revenue:

$4.33M

Net Income/Loss:

$-4.17M

P/E Ratio:

-1.4913

EPS:

-1.4953

Net Cash Flow:

$-3.19M

1W Performance:

+0.45%

1M Performance:

+36.81%

6M Performance:

+0.00%

1Y Performance:

-23.89%

1-Day Range:

$2.1701

$2.2456

1-Week Range:

$1.97

$2.3799

52-Week Range:

$1.45

$3.2133

Biomerica Inc Stock (BMRA) Company Profile

Name

Biomerica Inc

Sector

Healthcare (1069)

Industry

Medical Devices (140)

Phone

(949) 379-2875

Address

17571 VON KARMAN AVENUE, IRVINE, CA

Employee

Twitter

@biomerica_inc

Next Earnings Date

2026-10-13

Latest SEC Filings

BMRA's Discussions on Twitter

Compare BMRA vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BMRA Biomerica Inc	2.23	10.39M	4.33M	-4.17M	-3.19M	-1.4953
ABT Abbott Laboratories	103.36	182.09B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	91.62	117.54B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	270.01	105.63B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.10	65.16B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.77	49.67B	6.30B	1.07B	1.09B	1.8406

Biomerica Inc Stock (BMRA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-10-20	Initiated	Colliers Securities	Buy
Jan-04-18	Initiated	B. Riley FBR, Inc.	Buy

Biomerica Inc Stock (BMRA) Latest News

05:00 AM

Biomerica (BMRA) gets new B. Riley-linked shareholder - Stock Titan

05:00 AM

Sep 08, 2026

Biomerica (BMRA) finance chief discloses four stock option awards - Stock Titan

Sep 08, 2026

Sep 07, 2026

Biomerica Raises $2.23 Million as Quarterly Sales Rise 17% - Orange County Business Journal

Sep 07, 2026

Sep 03, 2026

BRC Group Holdings, Inc. Buys Biomerica Inc (BMRA) -- Shares Look 12% Overvalued on GF Value - GuruFocus

Sep 03, 2026

Sep 02, 2026

Biomerica director Gary M. Huff acquires $50,000 in BMRA stock By Investing.com - Investing.com Nigeria

Sep 02, 2026

Biomerica director Gary M. Huff acquires $50,000 in BMRA stock - Investing.com

Sep 02, 2026

Biomerica net loss hits USD 3.8M in 2026 - medicalbuyer.co.in

Sep 02, 2026

Sep 01, 2026

BRC Group Holdings Secures 10.03% Activist Stake in BIOMERICA INC (NASDAQ: BMRA) with $736,128 Investment - Kalkine Media

Sep 01, 2026

Biomerica Reports Fiscal 2026 Fourth-Quarter Sales Growth, Improved Full-Year Loss and Advances in inFoods IBS Commercialization - Quiver Quantitative

Sep 01, 2026

Aug 31, 2026

BIOMERICA INC FY 2026: Revenue $4.45M, EPS $(1.30) — 10-K Summary - TradingView

Aug 31, 2026

Biomerica : Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K) - marketscreener.com

Aug 31, 2026

Biomerica announces USD 2.23M financing - medicalbuyer.co.in

Aug 31, 2026

Aug 30, 2026

Biomerica, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Aug 30, 2026

Aug 28, 2026

B. Riley joins Biomerica (BMRA) as key investor and deal advisor - Stock Titan

Aug 28, 2026